BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Blasco-Benito S, Moreno E, Seijo-Vila M, Tundidor I, Andradas C, Caffarel MM, Caro-Villalobos M, Urigüen L, Diez-Alarcia R, Moreno-Bueno G, Hernández L, Manso L, Homar-Ruano P, McCormick PJ, Bibic L, Bernadó-Morales C, Arribas J, Canals M, Casadó V, Canela EI, Guzmán M, Pérez-Gómez E, Sánchez C. Therapeutic targeting of HER2-CB2R heteromers in HER2-positive breast cancer. Proc Natl Acad Sci U S A 2019;116:3863-72. [PMID: 30733293 DOI: 10.1073/pnas.1815034116] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 10.7] [Reference Citation Analysis]
Number Citing Articles
1 Gómez-cañas M, Rodríguez-cueto C, Satta V, Hernández-fisac I, Navarro E, Fernández-ruiz J. Endocannabinoid-Binding Receptors as Drug Targets. Methods in Molecular Biology 2023. [DOI: 10.1007/978-1-0716-2728-0_6] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Farooq Z, Howell LA, Mccormick PJ. Probing GPCR Dimerization Using Peptides. Front Endocrinol 2022;13:843770. [DOI: 10.3389/fendo.2022.843770] [Reference Citation Analysis]
3 Shoeib AM, Benson LN, Mu S, MacMillan-Crow LA, Prather PL. Non-Canonical Cannabinoid Receptors with Distinct Binding and Signaling Properties in Prostate and Other Cancer Cell Types Mediate Cell Death. Int J Mol Sci 2022;23:3049. [PMID: 35328467 DOI: 10.3390/ijms23063049] [Reference Citation Analysis]
4 Falasca V, Falasca M. Targeting the Endocannabinoidome in Pancreatic Cancer. Biomolecules 2022;12:320. [DOI: 10.3390/biom12020320] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
5 O'Brien K. Cannabidiol (CBD) in Cancer Management. Cancers (Basel) 2022;14:885. [PMID: 35205633 DOI: 10.3390/cancers14040885] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
6 Maggio R, Fasciani I, Carli M, Petragnano F, Marampon F, Rossi M, Scarselli M. Integration and Spatial Organization of Signaling by G Protein-Coupled Receptor Homo- and Heterodimers. Biomolecules 2021;11:1828. [PMID: 34944469 DOI: 10.3390/biom11121828] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Iozzo M, Sgrignani G, Comito G, Chiarugi P, Giannoni E. Endocannabinoid System and Tumour Microenvironment: New Intertwined Connections for Anticancer Approaches. Cells 2021;10:3396. [PMID: 34943903 DOI: 10.3390/cells10123396] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
8 Ramer R, Wittig F, Hinz B. The Endocannabinoid System as a Pharmacological Target for New Cancer Therapies. Cancers (Basel) 2021;13:5701. [PMID: 34830856 DOI: 10.3390/cancers13225701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
9 Oyagawa CRM, Grimsey NL. Cannabinoid receptor CB1 and CB2 interacting proteins: Techniques, progress and perspectives. Methods Cell Biol 2021;166:83-132. [PMID: 34752341 DOI: 10.1016/bs.mcb.2021.06.011] [Cited by in Crossref: 3] [Article Influence: 3.0] [Reference Citation Analysis]
10 Mangal N, Erridge S, Habib N, Sadanandam A, Reebye V, Sodergren MH. Cannabinoids in the landscape of cancer. J Cancer Res Clin Oncol 2021;147:2507-34. [PMID: 34259916 DOI: 10.1007/s00432-021-03710-7] [Cited by in Crossref: 14] [Cited by in F6Publishing: 19] [Article Influence: 14.0] [Reference Citation Analysis]
11 Thomas A, Schultz C, Laguerre A. Incorporation of unnatural amino acid for the tagging of cannabinoid receptors 1 and 2 reveals receptor roles in regulating cAMP levels.. [DOI: 10.1101/2021.06.09.447758] [Reference Citation Analysis]
12 Wang G, Li R, Parseh B, Du G. Prospects and challenges of anticancer agents' delivery via chitosan-based drug carriers to combat breast cancer: a review. Carbohydr Polym 2021;268:118192. [PMID: 34127212 DOI: 10.1016/j.carbpol.2021.118192] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 16.0] [Reference Citation Analysis]
13 Moreno E, Cavic M, Canela EI. Functional Fine-Tuning of Metabolic Pathways by the Endocannabinoid System-Implications for Health and Disease. Int J Mol Sci 2021;22:3661. [PMID: 33915889 DOI: 10.3390/ijms22073661] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
14 Kilpatrick LE, Hill SJ. Transactivation of G protein-coupled receptors (GPCRs) and receptor tyrosine kinases (RTKs): Recent insights using luminescence and fluorescence technologies. Curr Opin Endocr Metab Res 2021;16:102-12. [PMID: 33748531 DOI: 10.1016/j.coemr.2020.10.003] [Cited by in Crossref: 13] [Cited by in F6Publishing: 17] [Article Influence: 13.0] [Reference Citation Analysis]
15 de Lorimier L, Hazzah T, Amazonas E, Cital S. Cannabinoids in Oncology and Immune Response. Cannabis Therapy in Veterinary Medicine 2021. [DOI: 10.1007/978-3-030-68317-7_10] [Reference Citation Analysis]
16 Lei X, Chen X, Quan Y, Tao Y, Li J. Targeting CYP2J2 to Enhance the Anti-Glioma Efficacy of Cannabinoid Receptor 2 Stimulation by Inhibiting the Pro-Angiogenesis Function of M2 Microglia. Front Oncol 2020;10:574277. [PMID: 33330047 DOI: 10.3389/fonc.2020.574277] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
17 Moreno E, Cavic M, Krivokuca A, Canela EI. The Interplay between Cancer Biology and the Endocannabinoid System-Significance for Cancer Risk, Prognosis and Response to Treatment. Cancers (Basel) 2020;12:E3275. [PMID: 33167409 DOI: 10.3390/cancers12113275] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
18 Laguerre A, Keutler K, Hauke S, Schultz C. Regulation of Calcium Oscillations in β-Cells by Co-activated Cannabinoid Receptors. Cell Chem Biol 2021;28:88-96.e3. [PMID: 33147441 DOI: 10.1016/j.chembiol.2020.10.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
19 Schoeman R, Beukes N, Frost C. Cannabinoid Combination Induces Cytoplasmic Vacuolation in MCF-7 Breast Cancer Cells. Molecules 2020;25:E4682. [PMID: 33066359 DOI: 10.3390/molecules25204682] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 8.0] [Reference Citation Analysis]
20 Zhang Y. The root cause of drug resistance in HER2-positive breast cancer and the therapeutic approaches to overcoming the resistance. Pharmacol Ther 2021;218:107677. [PMID: 32898548 DOI: 10.1016/j.pharmthera.2020.107677] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
21 Lutz B. Neurobiology of cannabinoid receptor signaling
. Dialogues Clin Neurosci 2020;22:207-22. [PMID: 33162764 DOI: 10.31887/DCNS.2020.22.3/blutz] [Cited by in Crossref: 28] [Cited by in F6Publishing: 31] [Article Influence: 14.0] [Reference Citation Analysis]
22 Kanumuri R, Saravanan R, Pavithra V, Sundaram S, Rayala SK, Venkatraman G. Current trends and opportunities in targeting p21 activated kinase-1(PAK1) for therapeutic management of breast cancers. Gene 2020;760:144991. [PMID: 32717309 DOI: 10.1016/j.gene.2020.144991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
23 Tomko AM, Whynot EG, Ellis LD, Dupré DJ. Anti-Cancer Potential of Cannabinoids, Terpenes, and Flavonoids Present in Cannabis. Cancers (Basel) 2020;12:E1985. [PMID: 32708138 DOI: 10.3390/cancers12071985] [Cited by in Crossref: 44] [Cited by in F6Publishing: 51] [Article Influence: 22.0] [Reference Citation Analysis]
24 Almogi-Hazan O, Or R. Cannabis, the Endocannabinoid System and Immunity-the Journey from the Bedside to the Bench and Back. Int J Mol Sci 2020;21:E4448. [PMID: 32585801 DOI: 10.3390/ijms21124448] [Cited by in Crossref: 40] [Cited by in F6Publishing: 43] [Article Influence: 20.0] [Reference Citation Analysis]
25 Kovalchuk O, Kovalchuk I. Cannabinoids as anticancer therapeutic agents. Cell Cycle 2020;19:961-89. [PMID: 32249682 DOI: 10.1080/15384101.2020.1742952] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 15.5] [Reference Citation Analysis]
26 Contino M, McCormick PJ. Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain. Front Pharmacol 2020;11:312. [PMID: 32218737 DOI: 10.3389/fphar.2020.00312] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
27 Gaibar M, Beltrán L, Romero-Lorca A, Fernández-Santander A, Novillo A. Somatic Mutations in HER2 and Implications for Current Treatment Paradigms in HER2-Positive Breast Cancer. J Oncol 2020;2020:6375956. [PMID: 32256585 DOI: 10.1155/2020/6375956] [Cited by in Crossref: 18] [Cited by in F6Publishing: 22] [Article Influence: 9.0] [Reference Citation Analysis]
28 Almogi-Hazan O, Khuja I, Ritter S, Or R. The Highs and Lows of Cannabis in Cancer Treatment and Bone Marrow Transplantation. Rambam Maimonides Med J 2020;11. [PMID: 32017682 DOI: 10.5041/RMMJ.10391] [Reference Citation Analysis]
29 Laezza C, Pagano C, Navarra G, Pastorino O, Proto MC, Fiore D, Piscopo C, Gazzerro P, Bifulco M. The Endocannabinoid System: A Target for Cancer Treatment. Int J Mol Sci 2020;21:E747. [PMID: 31979368 DOI: 10.3390/ijms21030747] [Cited by in Crossref: 51] [Cited by in F6Publishing: 57] [Article Influence: 25.5] [Reference Citation Analysis]
30 Spinelli F, Giampietro R, Stefanachi A, Riganti C, Kopecka J, Abatematteo FS, Leonetti F, Colabufo NA, Mangiatordi GF, Nicolotti O, Perrone MG, Brea J, Loza MI, Infantino V, Abate C, Contino M. Design and synthesis of fluorescent ligands for the detection of cannabinoid type 2 receptor (CB2R). Eur J Med Chem 2020;188:112037. [PMID: 31954990 DOI: 10.1016/j.ejmech.2020.112037] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
31 Maccarrone M. Missing Pieces to the Endocannabinoid Puzzle. Trends Mol Med 2020;26:263-72. [PMID: 31822395 DOI: 10.1016/j.molmed.2019.11.002] [Cited by in Crossref: 44] [Cited by in F6Publishing: 47] [Article Influence: 14.7] [Reference Citation Analysis]
32 Casadó-anguera V, Cortés A, Casadó V, Moreno E. Targeting the receptor-based interactome of the dopamine D1 receptor: looking for heteromer-selective drugs. Expert Opinion on Drug Discovery 2019;14:1297-312. [DOI: 10.1080/17460441.2019.1664469] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
33 Moreno E, Cavic M, Krivokuca A, Casadó V, Canela E. The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet? Front Pharmacol 2019;10:339. [PMID: 31024307 DOI: 10.3389/fphar.2019.00339] [Cited by in Crossref: 69] [Cited by in F6Publishing: 70] [Article Influence: 23.0] [Reference Citation Analysis]